scholarly journals COMPLICATIONS OF AUGMENTATION MAMMOPLASTY

2020 ◽  
pp. 629-634
Author(s):  
I.V. SERGEEV ◽  
◽  
T.R. FAYZULLIN ◽  
D.P. LARIONOV ◽  
◽  
...  
Keyword(s):  
First Generation ◽  
Breast Implant ◽  
Capsular Contracture ◽  
Late Complication ◽  
Large Cell ◽  
Augmentation Mammoplasty ◽  
Double Bubble ◽  
Clear Idea

Augmentation mammoplasty is one of the most demanded and most frequently performed plastic surgeries in the world. The first breast augmentation using first-generation implants performed in 1962. Since, the surgery technique and the quality of implants have been improved. Although the number of complications significantly decreased, they still occur both in the early and the late postoperative periods. Often complications include seroma, hematoma, asymmetry, double bubble (double fold), implant displacement, rippling, capsular contracture, etc. The most formidable late complication described in 1997, is breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), which is manifested more than after a year, by the formation of the late malignant seroma after implantation. A review of modern literature provides a clear idea of the number of received complications. However, the pathogenesis of the development of some of them (capsular contracture, implant-associated lymphoma) is still unclear, and therefore, further long-term studies are needed to obtain more accurate data. Keywords: Augmentation mammoplasty, double fold (double bubble), capsular contracture, seroma, hematoma, implant-associated lymphoma.

scholarly journals Current Challenges in Breast Implantation

Medicina ◽  
2021 ◽  
Vol 57 (11) ◽  
pp. 1214
Author(s):  
Zuzanna Pelc ◽  
Magdalena Skórzewska ◽  
Andrzej Kurylcio ◽  
Paweł Olko ◽  
Joanna Dryka ◽  
...  
Keyword(s):  
Breast Implant ◽  
Diagnostic Procedures ◽  
Large Cell ◽  
The United Kingdom ◽  
Current State ◽  
Aesthetic Results ◽  
Short And Long Term ◽  
Breast Implantation

Breast implantation (BI) is the most common plastic surgery worldwide performed among women. Generally, BI is performed both in aesthetic and oncoplastic procedures. Recently, the prevalence of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) or breast implant illness (BII) has aroused concerns. As a result, several countries, like Australia, Korea or the United Kingdom, introduced national registries dedicated to the safety and quality of BI surgeries. This narrative review aimed to focus on the clinical challenges, management and the current state of knowledge of BI. Both short and long-term outcomes of BI are determined by various alternatives and differences, which surgeons must consider during the planning and performing breast augmentation along with further complications or risk of reoperation. Proper preoperative decisions and aspects of surgical technique emerged to be equally important. The number of performed breast reconstructions is increasing, providing the finest aesthetic results and improving patient’s quality of life. Choice of prosthesis varies according to individual preferences and anatomical variables. A newly diagnosed cases of BIA-ALCL with lacking data on prevention, diagnosis, and treatment are placing it as a compelling medical challenge. Similarly, BII remains one of the most controversial subjects in reconstructive breast surgery due to unspecified diagnostic procedures, and recommendations.

scholarly journals The A, B and C’s of Silicone Breast Implants: Anaplastic Large Cell Lymphoma, Biofilm and Capsular Contracture

Materials ◽  
2018 ◽  
Vol 11 (12) ◽  
pp. 2393 ◽  
Author(s):  
Maria Mempin ◽  
Honghua Hu ◽  
Durdana Chowdhury ◽  
Anand Deva ◽  
Karen Vickery
Keyword(s):  
Anaplastic Large Cell Lymphoma ◽  
Biofilm Formation ◽  
Cell Lymphoma ◽  
Breast Implant ◽  
Capsular Contracture ◽  
Breast Implants ◽  
Surface Characteristics ◽  
Large Cell ◽  
Breast Implantation ◽  
Large Cell Lymphoma

Breast implantation either for cosmetic or reconstructive e purposes is one of the most common procedures performed in plastic surgery. Biofilm infection is hypothesised to be involved in the development of both capsular contracture and anaplastic large cell lymphoma (ALCL). Capsular contracture is one of the principal reasons for breast revision surgery and is characterised by the tightening and hardening of the capsule surrounding the implant, and ALCL is an indolent lymphoma found only in women with textured implants. We describe the types of breast implants available with regard to their surface characteristics of surface area and roughness and how this might contribute to capsular contracture and/or biofilm formation. The pathogenesis of capsular contracture is thought to be due to biofilm formation on the implant, which results in on-going inflammation. We describe the current research into breast implant associated ALCL and how implant properties may affect its pathogenesis, with ALCL only occurring in women with textured implants.

scholarly journals Removal of fibroadenoma of the breast augmentation and breast implants. Analysis of the possibility of simultaneous and delayed execution of these operations

2021 ◽  
Vol 14 (2) ◽  
pp. 140-146
Author(s):  
Viktoriia Dzhuganova ◽  
Valery V. NOVOMLINSKY ◽  
Andrey Petrovich Sokolov ◽  
Pavel Alekseevich Lynov ◽  
Margarita Gennedievna Sokolova ◽  
...  
Keyword(s):  
Breast Augmentation ◽  
Capsular Contracture ◽  
Breast Implants ◽  
Needle Aspiration ◽  
Augmentation Mammoplasty ◽  
Simultaneous Treatment ◽  
Implant Placement ◽  
Simultaneous Operations ◽  
Cosmetic Effect

Introduction. Fibroadenomas (FA) are the most common benign breast neoplasms that are diagnosed in 25% of women. Dissatisfaction with the size of the breast and the desire to increase it occurs in 40%. For this reason, in the practice of a plastic surgeon, there are cases when the patient wants to remove fibroadenomas (FA) and increase the size of the breast. In this situation, there are two options for managing the patient- the simultaneous execution of two operations and the delayed one.Aim. To evaluate the possibility of simultaneous FA removal and augmentation mammoplasty, to analyze possible complications and methods of their correction.Materials and methods. We have analyzed the experience of simultaneous interventions of FA removal and augmentation mammoplasty on the example of 10 cases performed in the period from 2014-2019, as well as FA removal after implant placement-3 cases.Results. Performing a simultaneous operation has advantages due to the minimization of injuries (the ability to perform from a single access - submammary or periareolar), reducing psychological stress and better cosmetic effect. Two patients had postoperative complications in the form of capsular contracture, manifested in the asymmetry of the mammary glands, corrected by performing capsulotomy and forming a new submammary fold. When performing invasive diagnostic tests and surgical intervention in three patients after endoprosthesis augmentation mammoplasty, extreme caution was required due to the risk of violating the integrity of the implant. It was found that the incision of the posterior leaf of the MJ capsule with a large number of removed neoplasms in the postoperative period leads to the development of breast asymmetry. The fact of FA recurrence was also confirmed (2 patients), who subsequently underwent repeated surgical intervention.Conclusion. Performing simultaneous operations for benign breast tumors can be surely practiced by plastic surgeons, including as one of the options for simultaneous treatment of breast FA and augmentation mammoplasty. The occurrence of FA in the long-term period after breast augmentation surgery is associated with difficulties in diagnostics (mammography and fine needle aspiration biopsy under the control of ultrasound), as well as in the course of surgery itself, due to the presence of the implant and the risk of violation of its integrity.

Anaplastic Large Cell Lymphoma Arising in a Silicone Breast Implant Capsule: A Case Report and Review of the Literature

2003 ◽  
Vol 127 (3) ◽  
pp. e115-e118 ◽  
Author(s):  
Sunati Sahoo ◽  
Paul P. Rosen ◽  
Richard M. Feddersen ◽  
David S. Viswanatha ◽  
Douglas A. Clark ◽  
...  
Keyword(s):  
Anaplastic Large Cell Lymphoma ◽  
Cell Lymphoma ◽  
Breast Implant ◽  
Large Cell ◽  
Cell Phenotype ◽  
Augmentation Mammoplasty ◽  
Silicone Breast Implant ◽  
Rare Type ◽  
Breast Lymphoma ◽  
Large Cell Lymphoma

Abstract Anaplastic large cell lymphoma is a rare type of primary breast lymphoma. We report a case of anaplastic large cell lymphoma, T-cell phenotype, occurring in the periprosthetic capsule of a silicone breast prosthesis 9 years after implantation for augmentation mammoplasty. This case is unique for its unusual presentation.

scholarly journals Breast implant rupture 37 years after breast augmentation

2021 ◽  
pp. 69-69
Author(s):  
Marko Jovic ◽  
Ivan Radosavljevic ◽  
Jovan Mihaljevic ◽  
Jelena Jeremic ◽  
Milan Jovanovic
Keyword(s):  
Breast Augmentation ◽  
First Generation ◽  
Histopathological Examination ◽  
Breast Implant ◽  
Capsular Contracture ◽  
Surrounding Tissue ◽  
Silicone Implants ◽  
Complication Rates ◽  
Macroscopic Appearance ◽  
Implant Rupture

Introduction Silicone implants have been used ever since the second half of the 20th century. Over that period several generations of implants have been developed that differed in thickness of the shell and viscosity of the silicone gel. Development of these generations of implants was accompanied with different complication rates. The first-generation implants had the lowest tendency to rupture, but were more prone to capsular contracture and calcification formation. Case outline An 81-year-old female patient had her silicone implants placed in 1983. After a chest injury in 2015. on the lateral aspect of the left breast a tumefaction becomes palpable and she complains of pain. She denies any subjective problems before the injury. After pertinent diagnostic procedures and clinical examination, silicone implant rupture was suspected. Surgical findings confirmed ruptures of both implants so that they were extracted, capsulectomy was performed and the surrounding tissue imbibed with silicone removed. Samples were sent for histopathological examination. Conclusion Implant rupture is one of late complications of breast augmentation. The incidence of ruptures has changed with development of newer generations of silicone implants. We believe that our patient had the first-generation silicone implants, knowing the time from their placement to the occurrence of symptoms and macroscopic appearance of the shell after extraction. The fact is that these implants have proved to be very durable, but regardless of the lack of symptoms, current guidelines recommend regular screening for rupture, while possible preventive extraction, particularly in case of so old implants should be considered.

scholarly journals Research Related to Capsular Contracture after Breast Augmentation for Cosmetic or Reconstructive Purposes

2019 ◽  
Vol 70 (5) ◽  
pp. 1619-1624
Author(s):  
Silviu Adrian Marinescu ◽  
Dan Mircea Enescu ◽  
Catalin Gheorghe Bejinariu ◽  
Carmen Giuglea
Keyword(s):  
Breast Augmentation ◽  
Cell Lymphoma ◽  
Breast Implant ◽  
Capsular Contracture ◽  
Breast Implants ◽  
Large Cell ◽  
Upward Trend ◽  
Silicone Breast Implants ◽  
Number Of Patients ◽  
Alloplastic Breast Reconstruction

The upward trend of patients opting for elective breast augmentation, as well as the large number of patients benefiting from alloplastic breast reconstruction, require further studies on the safety profile of these techniques. Without any doubt, the incidence of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has drawn attention to the possible unknown complications characteristic of these procedures, creating the context of further studies devoted to this issue. The present research examines the capsular contracture rate on a group of 253 patients between 2015 and 2019, also proposing a scoring system based on the integration of the main diagnostic criteria related to the capsular contracture. The results of the literature review indicate that a lower incidence of capsular contracture could be achieved by using the newest techniques in the field involving the application of chemical substances on the surface of the latest generation of silicone breast implants.

scholarly journals Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 2: Therapeutic Issues

2020 ◽  
Vol 20 (8) ◽  
pp. 1144-1155 ◽  
Author(s):  
Renato Cozzi ◽  
Maria R. Ambrosio ◽  
Roberto Attanasio ◽  
Alessandro Bozzao ◽  
Laura De Marinis ◽  
...  
Keyword(s):  
First Generation ◽  
Somatostatin Analogs ◽  
Position Statement ◽  
Neurological Complications ◽  
Primary Treatment ◽  
Primary Treatment Modality ◽  
Therapeutic Tools ◽  
Clinical Conditions

Any newly diagnosed patient should be referred to a multidisciplinary team experienced in the treatment of pituitary adenomas. The therapeutic management of acromegaly always requires a personalized strategy. Normal age-matched IGF-I values are the treatment goal. Transsphenoidal surgery by an expert neurosurgeon is the primary treatment modality for most patients, especially if there are neurological complications. In patients with poor clinical conditions or who refuse surgery, primary medical treatment should be offered, firstly with somatostatin analogs (SSAs). In patients who do not reach hormonal targets with first-generation depot SSAs, a second pharmacological option with pasireotide LAR or pegvisomant (alone or combined with SSA) should be offered. Irradiation could be proposed to patients with surgical remnants who would like to be free from long-term medical therapies or those with persistent disease activity or tumor growth despite surgery or medical therapy. Since the therapeutic tools available enable therapeutic targets to be achieved in most cases, the challenge is to focus more on the quality of life.

Sign in / Sign up

Export Citation Format

Share Document